These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Novel indanyl-substituted imidazo[1,2-a]pyridines as potent reversible inhibitors of the gastric H+/K+-ATPase. Zimmermann PJ, Buhr W, Brehm C, Palmer AM, Feth MP, Senn-Bilfinger J, Simon WA. Bioorg Med Chem Lett; 2007 Oct 01; 17(19):5374-8. PubMed ID: 17723299 [Abstract] [Full Text] [Related]
6. 2-Phenyl and 2-heterocyclic-4-(3-(pyridin-2-yl)-1H-pyrazol-4-yl)pyridines as inhibitors of TGF-β1 and activin A signalling. Ciayadi R, Potdar M, Walton KL, Harrison CA, Kelso GF, Harris SJ, Hearn MT. Bioorg Med Chem Lett; 2011 Sep 15; 21(18):5642-5. PubMed ID: 21783359 [Abstract] [Full Text] [Related]
7. Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists. Baraldi PG, Tabrizi MA, Preti D, Bovero A, Romagnoli R, Fruttarolo F, Zaid NA, Moorman AR, Varani K, Gessi S, Merighi S, Borea PA. J Med Chem; 2004 Mar 11; 47(6):1434-47. PubMed ID: 14998332 [Abstract] [Full Text] [Related]
8. Synthesis and calcium channel-modulating effects of alkyl (or cycloalkyl) 1,4-dihydro-2,6-dimethyl-3-nitro-4-pyridyl-5-pyridinecarboxylate racemates and enantiomers. Ramesh M, Matowe WC, Akula MR, Vo D, Dagnino L, Li-Kwong-Ken MC, Wolowyk MW, Knaus EE. J Med Chem; 1998 Feb 12; 41(4):509-14. PubMed ID: 9484501 [Abstract] [Full Text] [Related]
10. Heterocyclic 1,7-disubstituted indole sulfonamides are potent and selective human EP3 receptor antagonists. Hategan G, Polozov AM, Zeller W, Cao H, Mishra RK, Kiselyov AS, Ramirez J, Halldorsdottir G, Andrésson T, Gurney ME, Singh J. Bioorg Med Chem Lett; 2009 Dec 01; 19(23):6797-800. PubMed ID: 19836233 [Abstract] [Full Text] [Related]
11. Anti-inflammatory profile of some synthesized heterocyclic pyridone and pyridine derivatives fused with steroidal structure. Amr AG, Abdulla MM. Bioorg Med Chem; 2006 Jul 01; 14(13):4341-52. PubMed ID: 16545570 [Abstract] [Full Text] [Related]
15. A general and efficient five-step one-pot procedure leading to nitrogen-bridgehead heterocycles containing an imidazole ring. Parenty AD, Song YF, Richmond CJ, Cronin L. Org Lett; 2007 Jun 07; 9(12):2253-6. PubMed ID: 17500559 [Abstract] [Full Text] [Related]
16. Discovery of biaryl inhibitors of H+/K+ ATPase. Garton N, Bailey N, Bamford M, Demont E, Farre-Gutierrez I, Hutley G, Bravi G, Pickering P. Bioorg Med Chem Lett; 2010 Feb 01; 20(3):1049-54. PubMed ID: 20053560 [Abstract] [Full Text] [Related]
17. Synthesis, antibacterial, and antiviral evaluation of new heterocycles containing the pyridine moiety. Salem MS, Sakr SI, El-Senousy WM, Madkour HM. Arch Pharm (Weinheim); 2013 Oct 01; 346(10):766-73. PubMed ID: 24105721 [Abstract] [Full Text] [Related]
18. QSARs of some novel isosteric heterocyclics with antifungal activity. Yalçin I, Oren I, Temiz O, Sener EA. Acta Biochim Pol; 2000 Oct 01; 47(2):481-6. PubMed ID: 11051213 [Abstract] [Full Text] [Related]
19. Nicotinamide derivatives as a new class of gastric H+/K(+)-ATPase inhibitors. 1. Synthesis and structure-activity relationships of N-substituted 2-(benzhydryl- and benzylsulfinyl)nicotinamides. Terauchi H, Tanitame A, Tada K, Nakamura K, Seto Y, Nishikawa Y. J Med Chem; 1997 Jan 31; 40(3):313-21. PubMed ID: 9022797 [Abstract] [Full Text] [Related]
20. Molecular modeling, design, synthesis, and biological activity of 1H-pyrrolo[2,3-c]pyridine-7-amine derivatives as potassium-competitive acid blockers. Arikawa Y, Hasuoka A, Hirase K, Inatomi N, Sato F, Hori Y, Takagi T, Tarui N, Kawamoto M, Kajino M. Chem Pharm Bull (Tokyo); 2014 Jan 31; 62(4):336-42. PubMed ID: 24695343 [Abstract] [Full Text] [Related] Page: [Next] [New Search]